• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • TheStreet Smarts
  1. Home
  2. / Investing

A Cannabis Consolidation Binge Is Creating Top Tier Companies

Two more major deals were announced on Tuesday.
By DEBRA BORCHARDT
Dec 22, 2020 | 01:30 PM EST
Stocks quotes in this article: APHA, TLRY, AYRWF, LHSIF, CCHWF, CRLBF

As the year comes to a close, the cannabis industry is on a consolidation binge. Two big deals were announced today piling on after last week's big move by Aphria (APHA) and Tilray (TLRY) . Ayr Strategies (AYRWF) is buying Liberty Health Science (LHSIF) in a deal valued at $290 million, and Columbia Care (CCHWF) is buying privately-held Green Leaf Medical in a deal valued at $240 million.

Ayr Strategies

Florida

Ayr Strategies has grown quickly through acquisition and this latest purchase gets the company exposure in two of the three best medical markets in the country. The all-stock deal for Liberty is valued at $290 million. In this transaction, Ayr will be getting Liberty's 387-acre cultivation campus in Gainesville, FL with over 300,000 sq. ft. of current production facilities in operation, 28 open retail dispensaries, seven completed and ready-to-open dispensaries, and seven dispensaries currently under construction. Liberty currently employs 335 people, all of whom are expected to be retained by Ayr. Ayr said it plans to spend approximately $15 million in capital expenditures in 2021 to improve and expand the Gainesville cultivation campus, as well as expand Liberty's dispensary footprint.

The fact that there was no cash involved in this transaction shows that Liberty was ready to deal. The company's CEO Victor Mancebo resigned in October after shareholders expressed dissatisfaction with the company's disappointing cannabis production in Florida. A recent state report from the Office of Medical Marijuana dated October 16-22 showed that Liberty, with 26 dispensing locations, had produced only 3,937,111 mg. of medical marijuana with THC. AltMed Florida, which also has 26 locations, produced 14,854,911 mg. of medical marijuana with THC. The same report listed Liberty producing 1,189,520 ounces of "marijuana in smoking form" while AltMed produced 3,410,551 ounces.

The same report showed that Liberty's sales fell 26% in the THC category, but rose 75% in flower sales. However, Liberty only sold 1,200 ounces of flower versus AltMed's 3,400 ounces of flower. While Liberty recorded a net income in the second quarter ending in August of $11.5 million, this was a huge drop from last year's net income of $23 million for the same time period.

In addition to the poor showing on production and sales, Liberty asked its debt holders for a 12-month extension on Senior Secured Convertible Debentures from the original November 22, 2020 maturity date, issued on November 22, 2017. They were offered to increase the interest from 12% to 13%. $6 million is currently outstanding. If Ayr Strategies can fix the issues at Liberty, the bones are there to really turn this portfolio into a promising operation. Surely the Liberty shareholders are pleased with this move.

New Jersey

In addition, Ayr said it was buying the membership interests in GSD NJ (Garden State Dispensaries), a licensed operator in New Jersey, for an upfront price of $101 million which includes $41 million in cash, $30 million in stock, and $30 million in the form of a promissory note. GSD has 30,000 sq. ft. of production space with another 75,000 sq. ft. of expansion space, and is one of only six operators that is approved to increase its footprint to roughly 150,000 sq. ft. GSD is the only licensee in the state that has already opened the maximum three store allotment allowed in this medical-only state. The company said on its call that the stores are running at a $10 million annualized rate. With the expectation that New Jersey will be legalizing adult use cannabis in 2021, this was a great time to acquire an original operator in the state. Including these and other pending transactions, Ayr said it will have operations in seven states covering 73 million people, which include four adult-use markets and three medical markets.

Columbia Care

Columbia Care Inc. is buying privately held Green Leaf Medical, LLC for approximately $240 million with the potential for additional performance-based milestone payments. Columbia will make a payment of $240 million, consisting of a cash payment of $45 million with the balance of $195 million being satisfied by the issuance of 43,900,144 common shares of the company. The deal is expected to close in the summer of 2021 and Columbia said the deal is immediately accretive.

Taking a page out of the Cresco Labs (CRLBF) playbook, Columbia is eyeing the wholesale markets in Pennsylvania and Maryland, and this deal helps push them to the top of the list. By acquiring Green Leaf, Columbia said it substantially expands its footprint and operating scale in the East Coast and Mid-Atlantic. It adds roughly 400,000 sq. ft. of cultivation and production capacity, four operating dispensaries and six undeveloped, but permitted dispensaries, in key limited license markets.

Green Leaf, better known as gLeaf, was founded in 2014. It was set to deliver $150 million in annual revenue for 2021 and produce almost 4,600 pounds of cannabis a month. Philip Goldberg is the CEO of gLeaf, which raised $10 million in April of this year, in order to expand operations in Virginia and acquire dispensaries in Pennsylvania.

"This combination affirms Columbia Care's position as one of the largest cultivators, manufacturers, and retailers in four key states - PA, VA, OH and MD - three of which are expected to convert from medical to adult-use in the next 24 months," said Nicholas Vita, CEO of Columbia Care.

Like Ayr, the company has also been on a buying binge. It acquired Green Solution this past summer in an all-stock deal, and in September it bought California-based Project Cannabis for $69 million. This latest acquisition is going to easily set Columbia Care in the top tier of cannabis companies in the U.S.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Debra Borchardt had no position in the securities mentioned.

TAGS: Investing | Markets | Stocks | Trading | Cannabis

More from Investing

Mega-Cap Tech Keeps Showing Wall Street Who's Boss

James "Rev Shark" DePorre
Jun 1, 2023 4:28 PM EDT

The action broadened on Thursday, but a small group of big stocks still dominated.

Dollar General Gets Busted Down to Lieutenant

Bruce Kamich
Jun 1, 2023 1:45 PM EDT

The charts advise marching in the other direction for this retailer.

New BlackRock Funds Rely on Brainpower

Mark Abssy
Jun 1, 2023 1:14 PM EDT

Artificial intelligence is all the rage, but the BlackRock Large Cap Value and the BlackRock Flexible Income exchange-traded funds offer a bit of human touch.

I Don't See Any Fireworks Coming From Macy's

Bruce Kamich
Jun 1, 2023 1:06 PM EDT

This iconic retailer appears only headed lower after posting earnings.

Here's How Investors Can Get in on Soaring Uranium Prices

Bruce Kamich
Jun 1, 2023 12:33 PM EDT

The charts of this fund are giving off a positive glow.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 06:54 PM EDT CHRIS VERSACE

    AAP Podcast: A Tongue -- and a Market -- Twister: 'Get a Debt Deal Done'

    Listen in as the Action Alerts PLUS Podcast tackle...
  • 12:07 PM EDT STEPHEN GUILFOYLE

    Selling Some of This Surging AI-Related Stock

    This isn't the only name in the Stocks Under $10 p...
  • 09:48 AM EDT CHRIS VERSACE

    AAP Podcast With Portillo's CEO!

    Listen in as we talk with a rising star in the Chi...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2023 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login